Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fibrogen Inc CS
(NQ:
FGEN
)
0.3655
-0.0045 (-1.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Fibrogen Inc CS
< Previous
1
2
3
4
5
6
7
Next >
FGEN Stock Earnings: FibroGen Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
FGEN stock results show that FibroGen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Nasdaq Surges Over 3%; Powell Industries Shares Spike Higher
July 31, 2024
Via
Benzinga
Dow Jumps Over 200 Points; Kraft Heinz Shares Gain After Q2 Earnings
July 31, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
One Year, Five Trial Failures: FibroGen Terminates Pancreatic Cancer Treatment Program
July 31, 2024
FibroGen reports topline results from late-stage trials of pamrevlumab for pancreatic cancer, failing to meet the primary endpoint of overall survival.
Via
Benzinga
Ground Cinnamon Recalls: What to Know as FDA Issues Alert Over Lead Levels
July 31, 2024
New ground cinnamon recalls are in effect as the FDA warns consumers about increased lead levels in some of these products.
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Why Are Chip Stocks Up Today?
July 31, 2024
Chip stocks are up today and investors wondering why will find all of the news explaining the rally in the sector on Wednesday.
Via
InvestorPlace
FibroGen Layoffs 2024: What to Know About the Latest FGEN Job Cuts
July 31, 2024
FibroGen layoffs are in the news Wednesday after the biopharmaceutical company announced plans to cut jobs after failed clinical trials.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Why is Macrogenics (MGNX) Stock Down 28% Today?
July 31, 2024
Macrogenics stock is down on Wednesday after MGNX investors learned that the company is discontinuing a Phase 2 clinical trial.
Via
InvestorPlace
Why Is FibroGen (FGEN) Stock Down 44% Today?
July 31, 2024
FibroGen stock is down on Wednesday as FGEN investors react to the company's failed clinical trials for its pancreatic cancer treatment.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 31, 2024
It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news happening this morning!
Via
InvestorPlace
Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
July 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 04, 2024
Via
Benzinga
What's Going On With FibroGen Stock Tuesday?
June 04, 2024
FibroGen Inc (NASDAQ:FGEN) shares are trading higher Tuesday morning after the company said the FDA cleared its Investigational New Drug (IND) of FG-3165. FibroGen also announced a new clinical trial...
Via
Benzinga
Exposures
Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 04, 2024
It's time to start Tuesday with a breakdown of the biggest pre-market stock movers traders will want to know about this morning!
Via
InvestorPlace
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
June 04, 2024
Via
Benzinga
FibroGen Stock Is Surging After The Bell: What's Going On?
June 03, 2024
FibroGen shares are moving higher in Monday's after-hours session after the company announced the FDA cleared its Investigational New Drug (IND) FG-3165. The company also announced a new clinical trial...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's After-Market Session
June 03, 2024
Via
Benzinga
7 Penny Biotech Stocks to Triple Your Investment
May 28, 2024
Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns.
Via
InvestorPlace
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 07, 2024
Via
Benzinga
FibroGen Shares Climb On Strong Q1 Sales
May 07, 2024
FibroGen reported quarterly losses of 33 cents per share which missed the analyst consensus estimate of $(0.31) and represents a 59.26% increase year-over-year. Quarterly sales clocked in at $55.902...
Via
Benzinga
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
May 07, 2024
Via
Benzinga
Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
May 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 07, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 07, 2024
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Tuesday!
Via
InvestorPlace
FGEN Stock Earnings: FibroGen Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
FGEN stock results show that FibroGen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 03, 2024
Via
Benzinga
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 03, 2024
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly...
Via
Benzinga
Exposures
Glyphosate
FibroGen Unveils Early Data From Prostate Cancer Candidate, Analyst Advocates Further Exploration In The Landscape
April 03, 2024
FibroGen reveals Phase 1 results for FG-3246 for metastatic castration-resistant prostate cancer. Promising efficacy metrics and plans for enhanced therapeutic strategies signal potential advancements...
Via
Benzinga
3 Nightmare Nasdaq Stocks Not Worth Holding Another Day
March 20, 2024
Selling these three NASDAQ stocks might be the best option now, as they continue to show potential issues and continued weakness.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.